Infarmed SRL
Infarmed reported total assets of 387,332 € at the end of the 2025 financial year (annual accounts filed with the NBB on 18 May 2026).
The score of Infarmed shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -3 % Total assets -36 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Infarmed's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −9,051 € | ||||
| Equity | 276,783 € | ||||
| Cash | 53,017 € | ||||
| EBITDA | 4,301 € | ||||
| Total assets | 387,332 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 May 2026
- Year ended 31 Dec 2024filed on 18 Aug 2025
- Year ended 31 Dec 2023filed on 16 Jul 2024
- Year ended 31 Dec 2022filed on 20 Jun 2023
- Year ended 31 Dec 2021filed on 07 Jul 2022
Infarmed's financial analysis
- Solvency71.5%sector median: 55.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Infarmed
Infarmed's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0437.680.232
- VAT number
- BE0437680232
- Peppol
- Registered · 0208:0437680232 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Jun 1989
- Registered office
- 3570 Alken
- Latest accounts
- 2025 · filed on 18 May 2026
- Activity
- Activities of general hospitals, except geriatric and specialised hospitals (NACE 86101)
Infarmed (SRL) has been based in Alken since 1989, active in: activities of general hospitals, except geriatric and specialised hospitals. For 2025, it reports a net loss of 9,051 € and equity of 276,783 €; its revenue is not published. Its solvency stands at 71.5%, above the median of its sector (55.9%).
Companies similar to Infarmed
Companies in the same business, of comparable size and area, outside its group.
- Sanchezthesia Hospital activities Etterbeek · balance sheet 273,404 €
- Soreleco Hospital activities Uccle · balance sheet 478,358 €
- Praksis Hospital activities Antwerp · balance sheet 507,882 €
- Dokter Prud’homme Patrick Hospital activities Eeklo · balance sheet 574,270 €
- Reanest Afia Hospital activities Saint-Gilles · balance sheet €1.24m
- B.H.R Clinic Hospital activities Auderghem · balance sheet 182,056 €
- Dr. Melis en Dr. Vandenbussche Hospital activities Bruges · balance sheet 365,390 €
- Behrmed Hospital activities Brussels · balance sheet 206,499 €
Frequently asked questions about Infarmed
What is the revenue of Infarmed?
Infarmed files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Infarmed?
In Belgium, the VAT number is the company number prefixed with BE: BE0437680232 for Infarmed, if the company is VAT-registered. Its company number (CBE) is 0437.680.232.
Where is the registered office of Infarmed?
According to the CBE register, the registered office of Infarmed is in 3570 Alken.
What is the equity of Infarmed?
At the close of the 2025 financial year, the equity of Infarmed amounts to 276,783 €, a solvency of 71.5% of total assets.
Who manages Infarmed?
The register lists 1 active mandates at Infarmed. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Infarmed
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →